AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Reflection on the Adoption of Disruptive Technologies in Dermatology

Description

The speaker reflects on their three decades of experience in health technology adoption, drawing parallels between early telehealth innovations and the current advancements in AI in dermatology. They emphasize the challenges faced during the initial phases of telemedicine, such as proving quality care and integrating technology into existing workflows. The presentation highlights the importance of learning from past experiences to navigate the adoption of AI, noting that both excitement and skepticism accompany the introduction of disruptive technology in healthcare. The speaker shares anecdotes of initial resistance from peers and patients towards telemedicine, likening it to current reactions to AI. They also discuss the need for substantial evidence supporting AI's efficacy and integration, addressing issues like reimbursement conundrums associated with software tools in healthcare. Key recommendations include focusing on practical applications of AI that can enhance workflow efficiency without overwhelming practitioners. Ultimately, the speaker encourages embracing innovation while considering the experiences learned from telemedicine to foster a smoother transition into the future of AI in healthcare.

View more

Conclusions

  • The evolution of telehealth offers valuable lessons for the adoption of AI in healthcare.
  • Successful adoption of AI will require demonstrating its quality comparable to telehealth.
  • Integration into clinical workflows and reimbursement frameworks are key factors for AI adoption.
  • The early skepticism and resistance faced by telehealth will likely parallel the challenges for AI.
  • Mistakes in the past illustrate the need to focus on patient value and the practical application of technology rather than just efficiency.
  • Human oversight is crucial in the initial phases of AI deployment to ensure safety and accuracy.
  • Establishing a strong evidence base will drive acceptance among healthcare professionals for AI solutions.
  • AI must address privacy, transparency, and safety concerns that differ from those encountered in telehealth.
  • Future AI applications should seek to enhance clinician efficiency rather than add to their workload.
  • Kvedar, J. C. Reflection on the adoption of disruptive technologies in dermatology. Immediate Past Chair, American Telemedicine Association. Editor-in-Chief, npj Digital Medicine.